Triage Performance and Physiological Predictors of Serious Illness in Febrile Children in the Pediatric Emergency Department
PEDTRIAGE
2 other identifiers
observational
3,000
1 country
10
Brief Summary
This multicenter prospective observational cohort study evaluates how well the initial triage category assigned by the Turkish Ministry of Health three-level color-coded triage system (Red-Yellow-Green) predicts serious clinical outcomes in children aged 0-18 years who present with fever to pediatric emergency departments. The study additionally assesses whether physiological parameters recorded at triage (heart rate, respiratory rate, oxygen saturation, capillary refill time, AVPU level of consciousness, and general appearance) provide independent and incremental prognostic value beyond the assigned triage category. Ten centers across Turkey will enroll consecutive eligible febrile children over a 3-month period. Routine clinical care and triage decisions are not altered by the study. The primary outcome is a composite serious clinical outcome. The study is reported in accordance with the STROBE and TRIPOD statements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2026
Shorter than P25 for all trials
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 27, 2026
CompletedFirst Posted
Study publicly available on registry
July 31, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
July 31, 2026
July 1, 2026
3 months
July 27, 2026
July 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Composite serious clinical outcome
Presence of at least one of: intensive care unit admission; invasive or non-invasive mechanical ventilation; vasopressor/inotropic therapy; culture- or sterile-body-fluid-confirmed invasive bacterial infection; 30-day mortality.
30 Dys
Secondary Outcomes (7)
Hospital admission with intravenous antibiotics
Up to 30 days
Sepsis protocol activation
Index ED visit (day 1)
Intravenous fluid bolus of at least 20 mL/kg
Index ED visit (day 1)
Unplanned re-attendance with admission
72 hours
All-cause hospital ward admission
Index ED visit (day 1)
- +2 more secondary outcomes
Study Arms (1)
Febrile children in the pediatric emergency department
Children aged 0-18 years presenting with fever (\>=38.0 C at triage or history of fever within the preceding 24 hours) to a participating pediatric emergency department during the 3-month study period. All undergo routine triage with the Ministry of Health three-level color-coded system; triage decisions and clinical care are not altered by the study.
Interventions
At presentation, each child is assigned a triage category (Red, Yellow, or Green) by the triage nurse using the Turkish Ministry of Health three-level color-coded system, and physiological parameters (heart rate, respiratory rate, oxygen saturation, capillary refill time, AVPU level of consciousness, and general appearance) are recorded on a standardized triage form. This reflects routine care and is not modified for the study.
Eligibility Criteria
Consecutive children aged 0-18 years presenting with fever to the participating pediatric emergency departments during the study period.
You may qualify if:
- Age 0-18 years
- Presentation to the pediatric emergency department
- Fever \>=38.0 C at triage OR history of fever within the preceding 24 hours
You may not qualify if:
- Presentation due to trauma
- Elective visits
- Missing triage data
- Re-attendance within 72 hours for the same episode (only the first visit is included)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- TC Erciyes Universitylead
- Kayseri City Hospitalcollaborator
- Adana City Training and Research Hospitalcollaborator
- Cukurova Universitycollaborator
- Akdeniz Universitycollaborator
- Manisa Celal Bayar Universitycollaborator
- Eskisehir Osmangazi Universitycollaborator
- Lütfi Kırdar City Hospitalcollaborator
- Dokuz Eylul Universitycollaborator
- Tokat Gaziosmanpasa Universitycollaborator
Study Sites (10)
Erciyes University Faculty of Medicine
Kayseri, Talas, 38039, Turkey (Türkiye)
Adana City Training and Research Hospital
Adana, Turkey (Türkiye)
Cukurova University Faculty of Medicine
Adana, Turkey (Türkiye)
Akdeniz University Faculty of Medicine
Antalya, Turkey (Türkiye)
Osmangazi University Faculty of Medicine
Eskişehir, Turkey (Türkiye)
Kartal Dr. Lutfi Kirdar City Hospital
Istanbul, Turkey (Türkiye)
Dokuz Eylul University Faculty of Medicine
Izmir, Turkey (Türkiye)
Kayseri City Hospital
Kayseri, Turkey (Türkiye)
Celal Bayar University Faculty of Medicine
Manisa, Turkey (Türkiye)
Tokat University Faculty of Medicine
Tokat Province, Turkey (Türkiye)
Related Publications (4)
Fleming S, Thompson M, Stevens R, Heneghan C, Pluddemann A, Maconochie I, Tarassenko L, Mant D. Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies. Lancet. 2011 Mar 19;377(9770):1011-8. doi: 10.1016/S0140-6736(10)62226-X.
PMID: 21411136BACKGROUNDRiley RD, Ensor J, Snell KIE, Harrell FE Jr, Martin GP, Reitsma JB, Moons KGM, Collins G, van Smeden M. Calculating the sample size required for developing a clinical prediction model. BMJ. 2020 Mar 18;368:m441. doi: 10.1136/bmj.m441. No abstract available.
PMID: 32188600BACKGROUNDvon Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007 Oct 20;370(9596):1453-7. doi: 10.1016/S0140-6736(07)61602-X.
PMID: 18064739BACKGROUNDCollins GS, Reitsma JB, Altman DG, Moons KG. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med. 2015 Jan 6;162(1):55-63. doi: 10.7326/M14-0697.
PMID: 25560714BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yilmaz Secilmis
TC Erciyes University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 27, 2026
First Posted
July 31, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
July 31, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared publicly. De-identified data may be made available from the coordinating center on reasonable request, subject to approval by the coordinating ethics committee and a data-sharing agreement, in accordance with institutional and national data-protection regulations.